Use of mobile phones for patient self-reporting adverse drug reactions: A pilot study at a tertiary hospital in Rwanda
- PDF / 874,584 Bytes
- 7 Pages / 595.276 x 790.866 pts Page_size
- 63 Downloads / 178 Views
ORIGINAL PAPER
Use of mobile phones for patient self‑reporting adverse drug reactions: A pilot study at a tertiary hospital in Rwanda Ntokamunda Justin Kadima1 · Ruth Nyiranteziryayo1 · Theoneste Umumararungu1 · Ahmed Adebowale Adedeji2,3 Received: 10 January 2020 / Accepted: 9 November 2020 © IUPESM and Springer-Verlag GmbH Germany, part of Springer Nature 2020
Abstract The use of mobile phones may avail early detection of adverse drug reactions (ADRs) in pharmacovigilance activities. The study aimed to explore the feasibility of outpatients to self-report ADRs using mobile phone technology and to picture such ADRs and medications received. Outpatients taking medications at the Gitwe hospital pharmacy during the study period were eligible, provided they were using a mobile phone and could talk about side effects. Participants were requested to call the investigator after one week of treatment or to accept a call from the investigator and answer some questions. The investigator collected the phone number and the prescribed medications of every participant. The data collected were analyzed to list all types of ADRs reported and match them with the actual side effects documented on each medication received. Of 80 patients enrolled, we called 79(98.75%) but one (1.25%) who called himself the investigator. Ten (12.5%) persons did not respond to the call. Of 70 respondents who picked calls, 36(51.43%) said not having experienced any side effects, and 34(48.57%) participants did. Dry cough, headache, dizziness, and swelling were dominant with14-21%. Two cases of heartbeat and dizziness pushed patients to return to the hospital. All respondents carried a functional mobile phone and demonstrated interest in self-reporting ADRs. Facilitated toll-free- call service may be an effective means of extending the scope of ADRs tracking in addition to the Yellow Card Scheme, and enhance the involvement of pharmacists and consumers in the pharmacovigilance programs. Keyword Pharmacovigilance · Adverse drug reactions · Mobile phones · Self-reporting · Rwanda Abbreviations ADR Adverse Drug Reaction CHUK Kigali University Hospital Center FDA Food and Drug Administration * Ntokamunda Justin Kadima [email protected] Ruth Nyiranteziryayo [email protected] Theoneste Umumararungu [email protected] Ahmed Adebowale Adedeji [email protected] 1
Department of Pharmacy, School of Medicine and Pharmacy, University of Rwanda, Huye campus, Butare, Rwanda
2
Department of Pharmacology, Faculty of Basic Medical Sciences, Olabisi Onabanjo University, Sagamu, Ago Iwuye, Nigeria
3
Foresight Institute of Research and Translation, Eleyele, Ibadan, Nigeria
GDH Gitwe District Hospital ICSR Individual Case Safety Report MoH Ministry of Health MQPNF Medicine Quality Problems Notification Forms NPMIC National Pharmacovigilance and Medicine Information Centre PIDM Program for International Drug Monitoring SOP Standard operating procedure USAID United States Agency for International Development WHO World He
Data Loading...
